Nutrition Issues in Critically Ill Children

Published on 22/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1311 times

95 Nutrition Issues in Critically Ill Children

Nutritional support is a central therapy in the management of critically ill patients. Specific populations such as premature infants have unique requirements, which are beyond the scope of this chapter. In contrast, term infants and older children appear to have a graduated set of nutritional/metabolic requirements based upon age and body size which ultimately achieve those requirements typically administered to adult patients. In caring for critically ill children, it is useful to understand the fundamental differences seen in children of differing ages and conditions. It is perhaps somewhat ironic that our well-intended efforts to “increase” nutritional support may at times lead to greater harm than benefit through the provision of protein, carbohydrate, and fat beyond what the critically ill child can utilize. In addition, metabolic complications such as total parenteral nutrition (TPN)-associated cholestasis, hepatic steatosis, and increased catheter-related infections are new morbidities that have arisen with the advent of advanced nutritional methods.

Recent reviews of the literature on nutritional support for critically ill children details the lack of definitive or reliable studies to guide our practice based upon scientific evidence.1,2 Therefore, many of the recommendations made rest upon “good practice” principles which rely upon expert consensus and avoidance of known harm whenever possible. The American Society of Parenteral and Enteral Nutrition (A.S.P.E.N.) has promulgated a set of expert guidelines for supporting critically ill children that represent a reasonable standard of care for children in the pediatric intensive care unit (PICU).3

The goal of this chapter is to provide the critical care clinician with a fundamental understanding of the issues necessary for providing effective and safe nutrition to acutely ill children in the PICU and those recovering from life-threatening illness. The material represents core concepts and approaches with wide acceptance by experts practicing in contemporary critical care where a range of enteral and parenteral nutrition aids are available.

image Role of Nutritional Support for Critically Ill Children

Contemporary nutritional support depends upon a balanced approach that provides macronutrients (e.g., protein or amino acids, carbohydrate, and fat) as well as a corresponding amount of micronutrients (e.g., minerals, trace elements, vitamins). While clinicians tend to take each of these components for granted, one must consider that the macronutrients must be processed via intermediary metabolic pathways to produce adenosine triphosphate (ATP) when and where needed and to provide structural molecules for tissue repair, maintenance of organ integrity, and immunoglobulin synthesis. The metabolic processes associated with biotransformation of macronutrients for both kidney and liver may produce further demands on organs that often are already working at limited capacity owing to perfusion deficits and humoral factors such as lipopolysaccharides (LPS), proinflammatory cytokines that tend to limit reserve capacity. Excess calories can be stored, whereas excess protein beyond what the body can utilize is rapidly degraded to urea as the final byproduct.

The protein pools of the body are conceptualized as existing in two compartments. The first compartment, referred to as the visceral protein pool, represents those proteins that can easily be accessed and degraded to provide amino acids when nutritional intake is inadequate. The visceral compartment includes plasma proteins, immunoglobulins, cytosolic enzymes, and so on that can be turned over readily. The second compartment, referred to as the somatic protein pool, represents primarily structural proteins in brain, heart, kidney, bone, and the like; this compartment is less accessible than the visceral pool. Protein is stored to a very limited extent when taken in beyond momentary need. Carbohydrate is generally stored to a limited extent as glycogen, beyond which it is converted into triglycerides under the influence of insulin. Fats must be taken up and cleared from the plasma through complex mechanisms involving lipoprotein lipase, which is impaired during stress states. Thus all three major macronutrients, when provided to patients by enteral or parenteral approach, depend upon a multitude of internal processes frequently altered by critical illness, leading to additional stress with no survival benefit. After decades of clinical research, the conclusion must be that excess nutritional support is to be avoided in favor of thoughtful moderation in providing nutrients.

Contemporary nutritional support has three primary goals: (1) preservation of lean body mass to minimize the catabolic consequence of critical illness, (2) provision of suitable substrates to permit restoration of immune function and repair of body tissues, and (3) prevention of nutrition-related complications including aspiration risks in patients receiving enteral nutrition and the avoidance of nutrient-induced organ overload, whether through excess carbohydrate (increased CO2 production and hepatic steatosis) or excess protein/nitrogen load to the liver and kidney. Understanding the risks and realistic benefits of nutritional support are vital in current PICU care.

image Impact of Physiologic Stress on Children

Alterations in protein and energy metabolism are hallmarks of critical illness and have been studied for many decades.4 This work has demonstrated a great difference between short-term starvation states in otherwise healthy individuals and the dramatic “autocannibalism” seen in critically ill patients who are not receiving appropriate nutritional support as summarized in Table 95-1.

TABLE 95-1 Comparison of Nutrient Metabolism in Starvation Versus Sepsis/Trauma

  Starvation Sepsis/Trauma
Protein breakdown ++ +++
Hepatic protein synthesis ++ ++++
Ureagenesis ++ ++++
Gluconeogenesis ++ ++++
Energy expenditure Reduced Increased
Mediator activity Low High
Hormone counterregulatory capacity Preserved Poor
Use of ketones +++ +
Loss of body stores Gradual Rapid
Primary fuels Fat Amino acids, glucose, triglycerides

Adapted from Barton R, Cerra FB. The hypermetabolism-multiple organ failure syndrome. Chest 1989;96:1153-60.

The events that lead to ICU admission are extremely varied, yet the body’s response to acute physiologic stress tends to be similar whether the inciting event is sepsis, ischemia-reperfusion, trauma, burns, or other inflammatory conditions. Beyond low levels of stress, such as minor elective surgery, life-threatening illness, burns, organ transplantation, or major surgical procedures elicit dramatic systemic inflammatory responses due to activation of the immune system, clotting mechanisms, and the endothelium. The patient’s ability to withstand the metabolic responses to such stresses and ultimately to reverse the process is central to recovery. A complete discussion of the metabolic response to stress is beyond the scope of this chapter; the reader is referred to other sources.5,6

The initial response to injury is to activate endothelial cells and to prime inflammatory cells such as neutrophils, macrophages, and lymphocytes through proinflammatory mediators including tumor necrosis factor, interleukin 2, histamine, eicosanoids, heat-shock proteins, free radicals, platelet-activating factor, and tryptases.7 These same signals that produce activation of the endothelium lead to permeability changes, activation of clotting mechanisms, and changes in hepatic and peripheral protein metabolism.8 If recovery is to occur, this process must be extinguished by a decrease in the inflammatory state and an increase in tissue repair.9 Although it may seem that simply shutting off the proinflammatory signals should lead to resolution, the process of resolving inflammation appears more complex.10 Studies show the importance of many of the proinflammatory stimuli in regeneration and repair, and the timing of interventions is important.11 In response to injury, a wide range of neurohumoral reactions occur, forming the classic “stress response,” which includes elevation of growth hormone, endogenous catecholamines, glucagon, and cortisol. Recognition of the role of insulin-like growth factor-1 along with growth hormone in promoting protein synthesis and counter-regulating inflammatory states suggests important potential treatment options that have been best studied in burns. Despite these studies showing benefit from growth hormone supplementation, evidence of increased mortality rate after growth hormone supplementation also has been reported.12 Clinicians must balance the relative benefit of hormonal manipulation with potential risks.

In the inflammatory state, unremitting gluconeogenesis occurs through the release of glycerol and gluconeogenic amino acids from the periphery with their conversion to glucose in the liver and kidney. Hyperglycemia frequently is associated with this state and may induce glycosuria and an osmotic diuresis. Insulin activity becomes impaired at the tissue level, leading to so-called insulin resistance in the face of the powerful gluconeogenesis driven by the stress hormones. It seems that the impairment of insulin results from decreased phosphorylation of the insulin receptor and second messengers.11 In the last decade, evidence from adult ICU experience has suggested a benefit from the use of insulin infusions to maintain tight control over serum glucose level.13 Although much of the preceding information derives from adult studies, it has found its way into contemporary pediatric practice in many centers in children of various ages. This question is receiving intense scrutiny in critically ill children through multicenter trials which are currently underway. The use of insulin infusions to control hyperglycemia in premature infants continues to be standard practice; however, the potential to produce marked hepatic steatosis under the influence of insulin should be born in mind when choosing the amount of carbohydrate to provide.

The breakdown of protein is a central theme in the body’s response to stress, which has wide-ranging significance beyond simple protein losses. The conversion of certain amino acids to glucose and the oxidation of others in peripheral tissues lead to the liberation of large quantities of amino-nitrogen, which would become toxic if not for the efficient conversion to urea. A dramatic increase in the rate of urea production is seen in critically ill patients. Concomitantly, other non-urea nitrogen is liberated in the form of uric acid and creatine and accounts for the dramatic increase in nitrogen wasting seen during stress states. Total urinary nitrogen losses in critically ill children may be 0.3 g/kg/d, which represents the loss of approximately 1.8 g/kg/d of whole protein catabolized. In parallel with the increased turnover of proteins, the metabolic rate for oxidation of energy substrates may increase following acute critical illness during the recovery phase (see subsequent section on energy expenditure).

The body’s response to withholding feeding (i.e., starvation) in healthy individuals is qualitatively and quantitatively different than that seen when nutrient intake is absent during critical illness. These differences are fundamental to understanding nutritional support in the ICU and are summarized in Table 95-1. In simple starvation, the body’s regulatory mechanisms for sparing lean tissue and using triglycerides as the primary energy source are intact, whereas under the influence of the stress response, rapid depletion of lean tissues occurs with oxidation of amino acids, carbohydrate, and fat as energy substrates.

One of the major consequences of life-threatening physiologic stress is the net depletion of body protein representing the somatic protein pool (e.g., skeletal muscle mass) and functional (e.g., plasma proteins, enzyme systems, antibodies) tissues contained in the visceral protein pool. With protein catabolism rates increased up to twofold, synthesis does not keep pace, and a state of negative nitrogen balance ensues when patients are not given adequate calories and protein.14 These changes produce depressed function of T and B lymphocytes, monocytes, and neutrophils as cumulative protein loss increases. The synthesis of antibodies, chemotaxis, phagocytosis, and bacterial killing is impaired in the face of advanced protein-calorie malnutrition.15 A decrease in total lymphocyte count may be seen in many patients, but a total lymphocyte count less than 1200/mm3 should raise concern for the presence of possible immune dysfunction. These alterations lead to impairment of host defense mechanisms. As noted earlier, for resolution of the inflammatory response, the patient’s immune system plays a central role in recovery of wound healing and recovery of immune competence.16 It is likely that the syndrome of multiple organ dysfunction seen in critically ill patients is due in part to the inability of the immune system to down-regulate the inflammatory response to injury in specific organs, as well as acquired mitochondrial dysfunction leading to ineffective cellular energy production.17 Nutritional support of a critically ill patient is thought to be essential to achieving recovery and minimizing the subsequent period of convalescence.

Considerable attention currently is focused on the use of modified nutritional support regimens in critically ill adults to modify the inflammatory response and reduce secondary organ system dysfunction.18 A wide range of substances have been studied in an attempt to improve outcome or minimize nitrogen loss during critical illness in specific populations of patients. Glutamine supplementation appears to benefit critically ill adults, particularly those with burns.18 Omega-3 fatty acids appear to also be beneficial in patients with sepsis and systemic inflammatory response syndrome (SIRS). The results in adults suggest that formulas supplemented with these products improve oxygenation and reduce the alveolar inflammatory response during acute respiratory distress syndrome (ARDS). While trials of these agents are underway in critically ill children, there is still not a strong enough consensus among pediatric specialists to consider their use as standard therapy.3

image Nutrition Assessment

The nutrition assessment of hospitalized children is a central and critical part of the initial examination and evaluation of all patients. The existence of chronic malnutrition as well as the development of acute malnutrition during critical illness has been recognized in pediatric critical care for many years1921 and appears to be an unmet need even today.22 Therefore, clinicians must assess newly admitted patients for the presence of malnutrition that may complicate the response to therapies or impair recovery (Box 95-1). The presence of previous severe malnutrition may complicate critical care management through the presence of marasmic cardiomyopathy, severe intracellular energy deficiency, and the development of refeeding disequilibrium when nutrients are provided in the ICU.23

Box 95-1

Assessment of Nutrition Status on Admission

*Actual height (cm) × 100/expected height at 50th percentile for age.

BMI (kg/m2) = body mass index: actual weight (kg)/[actual weight × height (m)] 2

From Statistics NCfH. CDC growth charts, United States, 2000. Available at: http://www.cdc.gov/growthcharts; and from Waterlow J. Classification and definition of protein-calorie malunutrition. Br J Med 1972;3:566-9.

The initial nutrition evaluation consists of assessing the patient’s weight, height, historical evidence for recent weight loss, and anthropometric measurements including midarm circumference and skinfold determination (when edema is not present). Nutrition history must include the presence and duration of nausea, vomiting, diarrhea, fever, frequent infections, fatigue, food aversion, abdominal discomfort, or feeding intolerance. For growth standards, norms exist reflecting age and gender.24 Ethnic background and considerations such as the presence of certain syndromes (e.g., Down syndrome) or the child’s birth status (e.g., premature, growth restricted, etc.) may affect the child’s growth status.

In particular, determination of body mass index (BMI, previously known as weight-for-height) for children older than 2 years of age provides important information regarding the previous nutritional status (see Box 95-1). In children younger than 2 years, the weight-for-age in light of the previous growth status is most useful. These straightforward measurements have withstood the test of time and were used by Pollack and coworkers to estimate the risk of malnutrition in critically ill children admitted to a multidisciplinary PICU.19,20,25 Their findings demonstrated higher rates of preexisting malnutrition than had been previously thought. In addition, there was an unexpected deterioration in nutrition indices following admission, suggesting the powerful effects of life-threatening illness on nutritional stores and status even with excellent clinical care. Clinicians caring for children who will experience more than a few days of hospitalization must therefore be especially aware of the potential for acquired nutritional depletion. Potential sources of error exist in interpreting anthropometric measurements that are primarily related to changes in body water associated with many acute critical illnesses in children (i.e., conditions producing capillary leak syndrome or defects in renal water clearance). Such conditions may invalidate the measurement of skinfold or midarm circumference; however, their longitudinal use in patients can be very useful in estimating the accretion of fat and lean tissue stores. It is standard practice to measure these parameters in patients at risk for malnutrition, such as those with cystic fibrosis, short bowel syndrome, and other conditions in which malabsorption or chronically elevated metabolic demands exist (e.g., congenital heart failure, bronchopulmonary dysplasia, and similar chronic conditions).

The triceps and scapular skin folds measure the subcutaneous tissue compartment (consisting primarily of adipose tissue) but also tissue edema in patients with anasarca from any cause. Triceps skin fold is measured by standardized skin caliper and is subject to considerable error if not performed in a consistent manner midway between the acromion and olecranon. The midarm circumference should be measured at the same point with a nonstretchable tape measure. The two indices taken together permit a reliable estimate of muscle mass. In general, good correlation exists between skinfold and arm circumference and weight-for-height percentile.26 During critical illness, anasarca may obscure the loss of lean tissue, which may only be apparent following resolution of edema when successful diuresis has occurred. A very reliable indicator of global loss of lean body mass can be seen in the wasting of the interosseous and thenar muscles of the hand, which becomes apparent 2 or 3 weeks after hospitalization with resolution of edema.

In addition to anthropometric measurements, longitudinal determination of specific plasma proteins including albumin, transferrin, and prealbumin have demonstrated value in assessing the response of patients to nutritional support. Frequently serum proteins will be decreased during acute critical illness without reflecting preceding malnutrition. This phenomenon occurs with capillary leak syndrome, seen in the first hours following PICU admission in patients with sepsis, cardiopulmonary bypass operations, ischemia-reperfusion injury, and similar stresses. Loss of endothelial barrier function causes large molecules such as albumin, which are normally three to four times more concentrated in the vascular compartment than in the interstitial fluid, to move into the extravascular space, lowering their concentration without a concomitant decrease in the total body pool of albumin. This effect may be very pronounced in patients who have received large volumes of crystalloid fluid during their resuscitation. Clinicians must guard against the tendency to replace albumin during acute critical illness solely based upon a low albumin level. Measures to correct the underlying pathophysiology should be considered before administering albumin. Serum albumin in healthy children is generally above 3.0 g/dL, and edema is rarely seen in otherwise healthy children until the albumin falls below 2.0 g/dL, such as in nephrotic syndrome.

Shorter half-life serum proteins such as prealbumin [T1/2 = 2 days] and transferrin [T1/2 = 7 days] also reflect nutrition status and respond more quickly to changes in anabolic state.27 As noted earlier, the pool of proteins in the plasma, interstitial space, and some intracellular proteins represent a relatively labile pool of protein referred to as the visceral protein pool. Visceral proteins are rapidly turned over relative to structural proteins that comprise the somatic protein pool. In critical illness, the synthesis of specific proteins such as C-reactive protein, ceruloplasmin, and α2-macroglobulin is increased, whereas the synthesis of other proteins such as albumin [T1/2 = ~20 days] is decreased.28 These changes may be seen within 6 hours of the onset of severe physiologic stress. This response to physiologic stress is under the regulation of complex neurohumoral control and is referred to as the acute phase response. It is largely responsible for the increase in erythrocyte sedimentation rate associated with acute inflammatory conditions.29 When followed longitudinally, the return of previously depressed levels of certain visceral proteins such as albumin, transferrin, retinol-binding protein, or prealbumin represents the abatement of physiologic stress or improvement in nutrition when levels are low due to protein-calorie malnutrition. Such positive changes herald the impending return to a state of growth and tissue accretion, barring reentry into a new inflammatory state.

image Energy Expenditure

All cellular processes require energy, generally in the form of ATP which is produced through oxidation of metabolic fuels, with heat and water as byproducts. The production of ATP is closely coupled to cellular metabolism and must be maintained to prevent cell death. As ATP levels fall, ionic gradients cannot be maintained, excitatory cells cannot depolarize, the synthesis of new cells and repair of damaged cell constituents cannot occur, and mechanical work such as cardiac pump function and respiratory activity cease. Thus, the body has numerous mechanisms for efficiently producing energy from a wide variety of substrates including protein, fat, and carbohydrates. Following the adaptation to decreased nutrient intake, an otherwise healthy individual will rely upon ketone bodies derived from the breakdown of fat stores to provide critical intracellular energy. Protein stores are relatively spared as the decrease in insulin output allows the metabolism to shift to a ketone-based state. As indicated in Table 95-1, critical illness prevents the body’s conservational mechanisms in response to decreased intake, leading to relatively rapid depletion of carbohydrate and available protein stores.

The close coupling between oxidative metabolism and substrate utilization is reflected in the amount of oxygen consumed (VO2) and carbon dioxide produced (VCO2) through the pathways of intermediary metabolism, which include the glycolytic pathway and the tricarboxylic acid cycle. Specific substrates such as fat, protein, and various carbohydrates have a characteristic relationship between VO2 and VCO2 based upon the stoichiometry of their unique oxidation. This relationship is referred to as the respiratory quotient (RQ = VCO2/VO2) and may be measured through the quantification of respiratory gas exchange through the patient’s lung. The overall metabolic rate is most easily determined in the clinical setting through the process of indirect calorimetry, a process that estimates the resting energy expenditure (REE) based upon VO2 and VCO2.30 Indirect calorimetry is well established in clinical nutrition but has been elusively difficult to perform with consistent results and easily applied technology in children. The respiratory quotient for fats is around 0.707 and for proteins around 0.80 and, in conjunction with urinary nitrogen determination, forms the basis for determining the specific substrates being utilized.30 This concept is demonstrated for the aerobic metabolism of glucose:

image

image

The availability of equipment to reliably perform indirect calorimetry in children has been a major obstacle to its widespread application. Several factors limit the reliability with which indirect calorimetry can be performed in young children, including non–steady state due to patient movement and nursing interventions, use of uncuffed endotracheal tubes producing loss of respiratory gases, high bias flows on infant ventilators, use of elevated inspired oxygen in nonintubated infants, as well as the small tidal volumes seen in the smallest patients. When indirect calorimetry is not feasible, VO2 can be calculated in many patients via the Fick equation (A × VdO2 × cardiac output) when a reliable measure of cardiac output is available. Based upon a conversion factor of approximately 5 kcal of energy per liter of oxygen consumed, one can closely estimate metabolic rate30 if the oxygen consumption is known and the RQ is assumed to be in a normal range.

Through indirect calorimetry it has become clear that patients with similar clinical appearances may have widely differing metabolic rates when adjusted for age and weight.3,3134 The differences may be as great as 300%, suggesting the potential for severe over- or undernutrition depending upon the values assumed.35 Thus, clinicians generally must rely upon information provided in controlled studies to guide the delivery of calories, since most will not have a means of easily determining the REE. A wide range of predictive equations have been devised which attempt to predict energy requirements of critically ill children, but it is clear that no single method of estimating caloric expenditures will be successful for all critically ill children.3,4,36

In very young infants, the effects of environmental cold stress is recognized as a source of unnecessary morbidity.37 The thermal neutral zone in infants up to 1 year of age tends to be several degrees higher than that for burned adults or older children. Heat lost to the environment produces rapid drops in core temperature in young children, with concomitant increase in metabolic demands. Maintaining the environment in a range of 30°C to 34°C with servo-controlled heaters or other means can significantly reduce energetic requirements in critically ill infants.

image Nutritional Support for the Critically Ill Child

Nutritional support for critically ill children is fundamentally different than conventional nutrition of healthy children because of the alterations in metabolism outlined previously. During periods of critical illness, utilization of nutrients for growth is markedly inhibited by hormonal response to stress and circulating inflammatory mediators. Utilization of calories for activity is much lower than under normal conditions. In addition, diet-induced thermogenesis is also affected in hospitalized patients by the different routes and formulations of nutrients provided. Estimates of increased caloric and protein requirements during acute illness and recovery indicate that compared to critically ill adults, children have greater requirements for both on a body weight basis. Therefore, one of the most important points for clinicians prescribing nutritional support is to provide calories in a thoughtful manner based upon the guidelines that follow and to avoid excess caloric intake during the acute phase of illness. During acute critical illness in children, many investigators have found REE to be less elevated than previously expected, with significant risk for overfeeding.33,35

Maintenance Fluids

Maintenance fluids for most patients can be estimated based upon body weight as indicated in Table 95-2. Children have generally increased requirements in relation to body weight for fluid, energy, protein, and many of the micronutrients. Water metabolism is closely coupled to metabolic activity because of the central role water plays in intermediary metabolism. For the term newborn, these amounts should be reduced during the first few days of life, owing to their increased intrinsic total body water. Premature infants have other considerations (e.g., high insensible losses), and consultation with a pediatrician or neonatologist is critical to provide appropriate and adequate fluid. Volumes must be increased for fever or persistent tachypnea to compensate for increased insensible fluid losses. Additional fluids must be provided to cover abnormal losses due to diarrhea, nasogastric drainage, or wound loss in burns or from other sites. Composition of the replacement fluid is based upon the content of sodium, potassium, bicarbonate, and chloride lost and conforms to conventional surgical and medical guidelines for fluid replacement. Typical maintenance fluids should provide sodium (3-5 mEq/kg/d) and potassium (2-3 mEq/kg/d) salts as well as a modest amount of glucose (5% or 10% if younger than 6 months of age). Recent trends in providing electrolytes has favored a balanced electrolyte solution that contains acetate salts of 1 to 2 mEq/kg/d to minimize development of hyperchloremic metabolic academia in the young child. Provision of glucose in maintenance fluids is intended to spare lean tissue through the elicitation of insulin release, which exerts an anticatabolic effect in minimally stressed patients.

TABLE 95-2 Approximate Parenteral Maintenance Fluid Requirements

Body Weight Fluid Volume (Parenterally)
First 10 kg 100 mL/kg/d
Second 10 kg 50 mL/kg/d
Additional kg 20 mL/kg/d

Prescribing Nutritional Support

The decision to provide nutrition via a parenteral or enteral route takes many factors into consideration, including anticipated time to resumption of normal dietary intake, available routes of nutrient administration, underlying metabolic or endocrine conditions, and the existence of organ dysfunction. When patients will not receive conventional nutrition for a prolonged period of time, it is appropriate to consider support via the gut or intravenously (IV). There is general agreement that the enteral route is superior to TPN when a patient is able to tolerate it. Advantages of the enteral route include better maintenance of gut structure and function, reduced bacterial translocation, fewer metabolic complications, decreased intrahepatic cholestasis, greater ease and safety of administration, better outcomes, and reduced cost.3

Nutrition is frequently started as soon as the patient is metabolically stable; however, reliable data regarding the necessity or benefits of nutritional support in the first 5 days of critical illness have not be convincing.3 For a critically ill patient, sufficient metabolic stability has been achieved when aggressive correction of electrolyte derangements has been achieved and the acid-base status no longer requires aggressive correction.

Once the decision has been made to start nutritional support, it is important to establish clear goals. During most acute critical illness, it is unreasonable to anticipate significant somatic growth, and the energy required for normal daily activities is markedly decreased. It is more realistic to employ nutritional support during this phase of illness to minimize the loss of lean body bass and support the synthesis of critical visceral proteins required for organ function, antibody production, and the mass of the immune system, as well as to provide substrate for wound healing. The requirements for nutrients can be divided into the macronutrients—consisting of carbohydrate, protein, and fat—and the micronutrients—consisting of minerals, vitamins, and trace elements. Vitamins and trace elements play key roles as essential cofactors in protein synthesis and intermediary metabolism.

Carbohydrate

Carbohydrate serves predominantly as an energy source. The carbon backbone of sugars also provides the basis for synthesis of many nonessential nutrients in the body. Carbohydrate is provided as sugars or starches in enteral formulas and as dextrose in parenteral nutrition. The caloric density of common dietary carbohydrate is generally 4 kcal/g, except for dextrose solutions, which provide 3.4 kcal/g because of energy lost through the process of hydration in solution. As the primary energy source, the rate of infusion should be adjusted to achieve the goals outlined in Table 95-3.

TABLE 95-3 Target Goals for Nonprotein Calories When Resting Energy Expenditure Determination Not Available

  Acute Phase
(First 3-5 Days; kcal/kg/d)
Convalescent Phase
(After 5 Days; kcal/kg/d)
Young children (<10 kg) 50-80 80-120
Children (1-7 years) 45-65 75-90
Children (>7 years) 30-50 30-75

In general, the cellular energy requirements of most critically ill children and adults can be met and euglycemia can be maintained through the infusion of 5 to 8 mg/kg/min of dextrose. This range represents about 25 to 40 kcal/kg/d of carbohydrate calories and is a close first approximation of basal energy expenditure seen in many hospitalized children. In healthy nonstressed individuals, ketosis ensues when glucose entry into the circulation falls below 1.5 to 2 mg/kg/min. As an additional point of reference, infusion of over 10 to 12 mg/kg/min of glucose results in net lipogenesis and excess carbon dioxide production in most hospitalized patients. When hyperglycemia develops in the face of appropriate rates of glucose infusion, it has become routine to administer insulin as a continuous infusion. Recent reports suggest that maintaining serum glucose in a narrow euglycemic range in critically ill adults may be associated with greater morbidity due to hypoglycemia and offers limited actual benefit.38 This practice has become commonplace in pediatric critical care, with several multicenter trials of this approach currently underway. Clinicians can expect the rate of insulin infusion required to control the serum glucose to be as much as 2 to 3 times higher than is routinely used in the treatment of diabetes as a result of the insulin resistance seen during critical illness.

Fat

Intravenous fat emulsions were originally developed to prevent essential fatty acid deficiency that can arise in a matter of days in critically ill children. A maximum of 20% to 30% of the caloric intake should be derived from fat. Intravenous fat should be infused as a 20% emulsion in infants to provide a concentrated calorie source (2 kcal/mL) as well as to supply essential fatty acids and lipid critical to central nervous system development and cell membrane repair. Intravenous fat emulsions are administered continuously unless rising plasma triglyceride levels suggest inadequate clearance. During periods of high physiologic stress, triglyceride levels are frequently elevated due to decreased peripheral clearance of triglycerides secondary to impaired lipoprotein lipase activity, increased generation of triglycerides from excess carbohydrate infusions, and elevation of lipolytic hormones in response to stress. To assess clearance, a minimum period of 4 hours without lipid infusion is needed to approximate the actual triglyceride level. A typical maximum for IV fat emulsion is 2.5 to 3.5 g/kg/d. Patients on enteral feedings may tolerate medium-chain triglycerides (MCT) better than long-chain fats following bowel injury or with right-sided heart failure. MCT are absorbed directly into the portal circulation, avoiding the complex absorptive process needed to digest long-chain fats. Formulas developed for patients with biliary disease typically contain a greater content of MCT, and many of the formulas developed for patients with absorption difficulties provide a significant portion of the triglyceride in the form of MCT.

Protein

Protein requirements are met through the provision of conventional enteral formulas or formulas containing hydrolysates of complex proteins that provide oligopeptides. Enteral formulas containing primary amino acids tend to be hypertonic with limited absorptive advantages, owing to the presence of mucosal transporter mechanisms that absorb di- and tripeptides more efficiently. The high rate of protein turnover during critical illness is associated with an increase in ureagenesis and urinary nitrogen losses that may amount to as much as 1 to 2 g/kg/d of protein equivalent. The supraphysiologic ureagenesis may represent additional metabolic stress on the liver and kidneys. To minimize nitrogen loss and assure that no amino acid falls to a level that would limit protein synthesis, high-quality nutritional protein must be given through the acute and convalescent phase of illness. Conceptually, proteins must be administered in amounts sufficient to replace losses, with additional protein to synthesize new tissue. Table 95-4 provides guidelines for the administration of protein to children in the ICU. It is important to recognize that nitrogen balance in response to nutritional support represents a continuum. In one recent study, the authors found that nitrogen balance was obtained at an intake of 2.8 g/kg/d.39 Positive nitrogen balance was only achieved with amino acid infusion rates at the upper end of those typically used by clinicians. Furthermore, calories must be provided in sufficient quantity to ensure that protein can be used for synthesis rather than as an energy substrate.

TABLE 95-4 Protein Requirements

  Acute Phase (First 3-5 Days; g/kg/d) Convalescent Phase (After 5 Days; g/kg/d)
Infants/Children < 7 years 1.5-2.5 2.0-3.0
Children > 7 years 1.5-2.0 1.5-2.0

The concept of calorie-to-nitrogen ratio derives from the concept that protein should be used for synthesis of functional and structural molecules rather than used as energy. Thus, energy must be provided in adequate amounts. For a typical healthy individual, the ratio of enteral nonprotein calories to nitrogen ranges from 250-350:1. Because of the obligatory oxidation of amino acids during catabolic states, the ratio of nonprotein calories to nitrogen is generally much lower, in the range of 100-250:1. This ratio provides a convenient method for checking that protein infusion is in line with nonprotein calories. Very low ratios suggest either excess protein delivery or inadequate calories.

Route of Administration

Nutrition should be provided via the gastrointestinal tract whenever possible, supplementing with peripheral or central parenteral nutrition when adequate enteral intake cannot be achieved.3 In patients with significant burns, an enteral feeding tube should be placed within the first hours of hospitalization. Continuous drip feedings should begin within hours to minimize bowel dysmotility and feeding intolerance often seen if feeding is delayed in such patients. In other patients, initiating feedings on the second hospital day is feasible in most cases and should be provided initially as a continuous infusion at a minimal rate of about 1 mL/kg/h and advanced as tolerated. The provision of trophic feedings is thought to provide a number of benefits even though significant nutritional intake cannot be achieved. These benefits include maintenance of gut motility, improved mesenteric blood flow, the release of trophic factors from the gut and pancreas, which maintain enterocyte mass and hepatocyte function.42 In addition, enterocytes derive a significant portion of their nutrient and energetic requirements from the luminal contents during digestion, making enteral nutrition ideal when tolerated.

During acute critical illness, continuous drip feedings are often better tolerated than bolus feedings, especially in patients with respiratory distress. Transpyloric feeding when possible via weighted Silastic feeding tubes should be used to minimize the risk of gastroesophageal reflux and aspiration. It has been used with excellent results in critically ill children.43 Placement of transpyloric feeding tubes can be done blindly by some experienced clinicians44 or may be done by a radiologist under fluoroscopic guidance. Occasionally, metoclopramide or erythromycin may facilitate passage of a transpyloric tube. Even when a transpyloric feeding tube cannot be placed, continuous enteral feeding via a nasogastric tube may confer most of the benefits, although the risk of gastroesophageal reflux is somewhat greater. For young infants, the availability of breast milk is the optimal nutrient source and can be easily delivered by feeding tube when the infant cannot nurse. In older patients, the initial enteral nutrition formula for most critically ill children should be lactose free, have some of the fat provided as medium-chain triglycerides, and contain easily absorbed proteins such as di- and tripeptides (see earlier discussion). Most of the currently available formulas developed for children between the ages of 1 and 10 years of age conform to these recommendations. A wide variety of formulas exist; availability may vary from region to region. The hospital dietitian is best prepared to help select appropriate formulas and knows which products are available locally.

While beyond the scope of the current discussion, special considerations for premature infants and newborns include the use of formulas supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA).45 DHA and ARA are long-chain polyunsaturated fatty acids found in breast milk and recently added to infant formulas. Their importance in infant nutrition was recognized by the rapid accretion of these fatty acids in the brain during the first postnatal year. Subsequent reports of enhanced intellectual development in breastfed children and recognition of the physiologic importance of DHA in visual and neural systems from studies in animal models has led to formulas being developed that contain them.46 It is becoming routine in the neonatal population to supplement DHA and ARA when providing enteral feedings.

Infants younger than 6 months of age should receive isotonic or hypotonic feedings initially until tolerance has been demonstrated. Young children between 1 and 5 years of age should receive an age-appropriate formula or an adult formula with appropriate supplements of protein, vitamins, and trace elements. Critically ill children older than 10 generally tolerate enteral formulas developed for adult patients, with supplementation of vitamins and micronutrients as needed for age. Enteral formulas should be initially iso- or hypotonic in order to minimize the possibility of diarrhea from excess osmotic load to the gut and to facilitate absorption. Infusion rates are begun conservatively at around 1 mL/kg/h, with a stepwise increase every 4 to 6 hours as tolerated up to the desired final rate. Once an acceptable rate is achieved, caloric density may be increased as tolerated. The clinician must maintain vigilance for evidence of feeding intolerance. In patients with poor tissue perfusion, enteral feedings are feasible; however, the risk of necrotizing enterocolitis is increased slightly when using the gut for nutrition. Thus, any signs of pronounced abdominal distension, profuse diarrhea, severe gastroesophageal reflux, or development of a new metabolic acidemia should lead to a hold on feedings and assessment of the abdomen prior to reinstituting feedings. Common manifestations of enteral feeding intolerance are outlined in Table 95-6.

TABLE 95-6 Enteral Feeding Intolerance

Problem Possible Reason Possible Remedy
Diarrhea, malabsorption Delivery too fast Decrease delivery rate
High osmotic load Reduce osmolarity or volume
Mucosal injury Start TPN, continuous slow enteral feeding to allow bowel recovery
Substrate intolerance Use elemental formula, especially disaccharide-free with MCT
Gastric retention/gastroesophageal reflux Hypertonic formula Decrease osmolarity, dilute.
High long-chain fat content Change to MCT containing formula
Hypodynamic gut Positioning right-side down, consider prokinetic agent (e.g., Reglan, opiate antagonist)
Abdominal distension Ileus, constipation R/O surgical abdomen, R/O constipation
  Add bulking agent or stool softener

MCT, medium-chain triglycerides; R/O, rule out; TPN, total parenteral nutrition.

Parenteral Nutrition

One of the great achievements of nutrition science has been the development of effective and safe nutrients to provide IV TPN over prolonged periods of time. For critically ill infants and children, TPN has been invaluable in the survival of premature infants, children with congenital or acquired bowel defects, and those who do not tolerate enteral nutrition due to malabsorption, surgery, or other causes of bowel dysfunction. However, we have learned that TPN may come with a significant cost in terms of iatrogenic electrolyte and acid-base disturbance, cholestasis, and hepatic fibrosis. Following prolonged TPN, especially in infants with short-bowel syndrome, excess carbon dioxide production and increased risk of bacterial and fungal infection are known problems. The goals of TPN support during critical illness should be clarified and kept realistic to avoid adding unnecessary metabolic stress to already compromised pulmonary, renal, and hepatic function. Excess TPN may contribute to organ dysfunction by increasing demands on those organs to regulate nutrients infused directly into the circulation, bypassing the first-pass counter-regulation that occurs with enteral nutrition.

Amino acid solutions developed for neonates (e.g., TrophAmine, which contains taurine, tyrosine, cysteine, and histidine) provide an advantage for select newborns and young infants with biliary disease, sepsis, or under high physiologic stress. This effect derives from increased branched-chain amino acids, the presence of amino acids which are conditionally “essential-for-age” in infants, and a reduction in nonessential amino acids. In premature infants or those on prolonged TPN, IV carnitine supplementation has been advocated to aid in triglyceride clearance through enhanced beta-oxidation of fatty acids.47 In older children, conventional amino acid solutions provide adequate dietary nitrogen.

The provision of nutrients via TPN should be consistent with the guidelines set forth previously. Although an occasional patient may become acutely glucose intolerant or experience dramatic electrolyte changes following initiation of TPN, most patients will tolerate it well and can be advanced to full TPN within just a few days. Pediatricians have had a habit of starting with dilute solutions of TPN and increasing both protein and calorie intake slowly over many days as tolerance is demonstrated. This approach has little scientific basis so long as nurses and physicians observe for signs of intolerance such as hyperglycemia, glycosuria, acidemia, and hyperlipidemia.

A key point to getting patients quickly up to their desired goal is to order the TPN solution at the intended final concentration and begin at half the intended ultimate infusion rate. For example, if the goal for TPN will be a 20% dextrose solution with 2 g/kg/d of protein to run at 44 mL/hr, the pharmacy can compound that goal solution, but it should be started at 22 mL/h until tolerance is demonstrated by glucose monitoring. For comparison, this rate of infusion would be equivalent to a 10% solution with 1 g/kg/d of protein if it were running at the full 44 mL/h, a formulation most clinicians would be comfortable starting. If the patient tolerates the infusion (e.g., no acidemia, hyperglycemia, glycosuria) for 6 to 8 hours at the slower rate, the solution can be increased to 33 mL/h. After an additional period of demonstrated tolerance, the solution is increased to its intended final rate. This approach reduces the potential to waste TPN and reduces a source of possible error in compounding the subsequent days’ TPN. Daily changes in electrolyte content must be made as indicated by serum levels. The essential issue when taking this approach is to supplement with conventional maintenance IV fluids while the TPN is being increased. Another useful approach to pediatric TPN is to plan for the entire day’s nutrients to be placed in a volume of fluids equal to half to two-thirds of the total allowed daily fluid volume. The remaining maintenance volume of fluid is made up with proprietary crystalloid, maintenance solutions that can be increased or decreased as demanded by the patient’s fluid status without affecting the amount of nutrients delivered. Taking this approach also lets the clinician reduce total fluid intake without sacrificing prescribed nutritional support. Using the two solutions allows one to titrate intake as required by changing clinical situations without abandoning TPN for day completely.

image Assessment of Response to Nutritional Support

It is important to monitor the response to nutritional support. Intolerance of enteral support frequently manifests through abdominal distension, vomiting, or other physical signs. With TPN, intolerance manifests in iatrogenic derangements of minerals, electrolytes, and acid-base status. Hyperglycemia was discussed previously but may represent a complication of TPN administration. Standard nutrition assessment should be considered for each patient after the initial stress phase of critical illness. End-organ response to nutritional support is monitored by assessing whether serum transferrin or prealbumin is rising or falling and whether genuine weight gain is occurring in convalescing patients.

In some circumstances, a patient may not respond adequately to nutritional support and may benefit from a more detailed examination including the measurement of albumin, total protein, and transferrin, a 24-hour urine collection for nitrogen balance determination, and if possible, measurement of energy expenditure via indirect calorimetry. However, in general such a detailed and cumbersome approach has not consistently improved the status of the critically ill child. In circumstances in which clinicians believe the response to nutritional support could be improved, a consultation with a pediatric dietitian or gastroenterologist may be required. The use of total urinary nitrogen determination to assess nitrogen balance in critically ill children remains more useful in research studies than in practical patient care. Finally, indirect calorimetry can provide practical information regarding overall energy expenditure and substrate utilization when cardiopulmonary function is stable and lactic acidosis is not present; however, its utility in improving patient outcomes has not been confirmed.

Annotated References

Pollack MM, Ruttiman UE, Wiley JS. Nutritional depletions in critically ill children: associations with physiologic instability and increased quantity of care. JPEN J Parenter Enteral Nutr. 1985;9:309-313.

A classic work highlighting earlier observations of early nutritional depletion in critically ill children and the ramifications for physiologic stability and intensity of care. Brings together Pollack’s earlier work on malnutrition in the PICU with his interest in physiologic stability, which set the stage for developing the PRISM scoring system.

Joffe Joffe A, Anton N, Lequier L, Vandermeer B, Tjosvold L, Larsen B et al. Nutritional support for critically ill children. Cochrane Database Syst Rev 2009;2:CD005144.

An up-to-date assessment of the evidence base for nutritional support in critically ill children, with a good review of the extant literature and its reliability in clinical management.

Mehta NM, Compher C, A.S.P.E.N. Board of Directors. Clinical Guidelines: nutrition support of the critically ill child. JPEN J Parenter Enteral Nutr. 2009;33:260-276.

A comprehensive review and evaluation of the research behind current feeding guidelines for critically ill children. Contains excellent references and basic information for prescribing nutritional support. Discusses caloric, macro-, and micronutrient guidelines as well as aspects of immunomodulatory nutrition pertaining to children.

Le HD, Fallon EM, de Meijer VE, Malkan AD, Puder M, Gura KM. Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg. 2010;19:27-34.

A review of the unique nutritional considerations in caring for patients with short-bowel syndrome and intestinal failure. Discusses strategies for managing liver disease associated with intestinal failure and long-term parenteral nutrition.

Diamond IR, Pencharz PB, Wales PW. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome? Minerva Pediatr. 2009;61:263-272.

Contemporary discussion of omega-3 fatty acid supplementation in liver failure associated with long-term parenteral nutrition. Provides a good discussion of the theory behind the use of omega-3 supplements and provides a basis for clinicians to understand the increasing role omega-3 fatty acids may play in clinical medicine.

References

1 Skillman H, Wischmeyer P. Nutrition therapy in critically ill infants and children. JPEN J Parenter Enteral Nutr. 2008;32:520-534.

2 Joffe A, et al. Nutritional support for critically ill children. Cochrane Database Syst Rev. 2009;2:1-10.

3 Mehta N, Compher C, et alA.S.P.E.N. Clinical guidelines: nutrition support of the critically ill child. JPEN J Parenter Enteral Nutr. 2009;33:260-276.

4 Mehta N, Jaksic T. The critically ill child, in Nutrition in Pediatrics. Duggan C. Watkins J. Walker W. Hamilton, ON: BC Decker; 2008:663-673.

5 Anand KJS. The stress response to surgical trauma: From physiological basis to therapeutic implications. Prog Food Nutr Sci. 1986;10:67-132.

6 Wesley J. Nutrient metabolism in relation to the systemic stress response. In: Fuhrman B, Zimmerman J, editors. Pediatric Critical Care. St. Louis: Mosby; 1998:799-819.

7 Hill A. Initiators and propogators of the metabolic response to injury. World J Surg. 2000;24:624-629.

8 Nathan C. Points of control in inflammation. Nature. 2002;420:846-852.

9 Lin L, Hopf H. Paradigm of the injury-repair continuum during critical illness. Crit Care Med. 2003;31S:S493-S495.

10 Ward N, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008;29:617-625.

11 Shipman J, Guy J, Abumrad N. Repair of metabolic processes. Crit Care Med. 2003;31S:S512-S517.

12 Takala J, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999;341:785-792.

13 van den Berghe G, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med. 2001;345:1417-1418.

14 Shew S, Jaksic T. The metablic needs of critically ill children and neonates. Semin Pediatr Surg. 1999;8:131-139.

15 Calvano S. Hormonal mediation of immune dysfunction following thermal and traumatic injury. In: Gallin J, Fauci A, editors. Advances in host defense mechanisms. New York: Raen Press, 1986.

16 Ayala A, et al. Mechanisms of immune resolution. Crit Care Med. 2003;31S:S558-S571.

17 Dare A, et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radical Bio Med. 2009;47:1517-1525.

18 Marik P, Zaloga G. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008;34:1980-1990.

19 Pollack M, et al. Malnutrition in critically-ill infants and children. JPEN J Parenter Enteral Nutr. 1982;6:20-24.

20 Pollack M, Wiley J, Holbrook P. Early nutritional depletion in critically ill children. Crit Care Med. 1981;9:580-583.

21 Pollack M, Ruttiman U, Wiley J. Nutritional depletions in critically ill children: associations with physiologic instability and increased quantity of care. JPEN J Parenter Enteral Nutr. 1985;9:309-313.

22 Mehta N, Duggan C. Nutritional deficiencies during critical illness. Pediatr Clin N Am. 2009;556:1143-1160.

23 Fuentebella J, Kerner J. Refeeding syndrome. Pediatr Clin N Am. 2009;56:1201-1210.

24 Statistics NCfH. CDC growth charts. United States, 2000. Available from. http://www.cdc.gov/growthcharts/.

25 Waterlow J. Classification and definition of protein-calorie malunutrition. Br J Med. 1972;3:566-569.

26 Carter P, et al. Nutritional parameters in children with cancer. J Am Diet Assoc. 1983;82:616-622.

27 Fletcher J, Little J, Guest P. A comparison of serum transferrin and serum prealbumin as nutritional parameters. JPEN J Parenter Enteral Nutr. 1987;11:144-147.

28 Fleck A, Colley C, Myers M. Liver export proteins and trauma. Br Med Bull. 1985;41:265-273.

29 Pannen B, Robotham J. The acute phase response. New Horizons. 1995;3:183-197.

30 Bursztein S, et al. Energy metabolism, indirect calorimetry, and nutrition. Baltimore: Williams & Wilkins; 1989.

31 Chwals W, et al. Measured energy expenditure in critically ill infants and young children. J Surg Res. 1988;44:467-472.

32 Verhoeven J, et al. Comparison of measured and predicted energy expenditure in mechanically ventilated children. Intensive Care Med. 1998;24:464-468.

33 Briassoulis G, Venkataraman S, Thompson A. Energy expenditure in critically ill children. Crit Care Med. 2000;28:1166-1172.

34 Turi R, et al. Energy metabolism of infants and children with systemic inflammatory resonse syndrome and sepsis. Ann Surg. 2001;233:581-587.

35 Chwals W. Overfeeding the critically ill child: fact or fantasy? New Horizons. 1994;2:147-155.

36 Coss-Bu J, et al. Resting energy expenditure in children in a pediatric intensive care unit: comparison of Harrisedict and Talbot predications with indirect calorimetry values. Am J Clin Nutr. 1998;67:74-80.

37 Soll R. Heat loss prevention in neonates. J Perinatol. 2008;28:S57-S59.

38 Griesdale D, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ Can Med Assoc J. 2009;180:821-827.

39 Coss-Bu J, et al. Resting energy expenditure and nitrogen balance in critically ill pediatric patients on mechanical ventilation. Nutrition. 1998;14:649-652.

40 Zappitelli M, et al. Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children. Intensive Care Med. 2009;35:698-706.

41 Energy and protein requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. Geneva: World Health Organization; 1985.

42 Schmidt H, Martindale R. The gastrointestinal tract in critical illness: nutritional implications. Curr Opin Clin Nutr Metab Care. 2003;6:587-591.

43 Mehta N. Approach to enteral feeding in the PICU. Nutr Clin Practice. 2009;24:377-387.

44 Joffe A, et al. Validation of a blind transpyloric feeding tube placement technique in pediatric intensive care: rapid, simple, and highly successful. Pediatr Crit Care Med. 2000;1:151-155.

45 Auestad N, et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics. 2003;112:e177-e183.

46 Birch E, et al. The DIAMOND (DHA Intake and Measurement of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr. 2010;91:848-859.

47 Cairns P, Stalker D. Carnitine supplementation of parenterally fed neonates. Cochrane Database Syst Rev 2000;4:CD000950.